One-Two Punch of Drugs Better Than Either Alone Against Colorectal Cancer

CU lab study and clinical trial target two of the most commonly mutated gene signaling pathways in cancer, at the same time.

Read the rest of this entry

“Dramatic” Early Phase 1 Results for AG-120 in IDH1 Mutated AML

“Extremely promising” early phase 1 clinical trial results for the investigational drug AG-120 against the subset of patients with acute myeloid leukemia (AML) harboring mutations in the gene IDH1.

Read the rest of this entry

Study Shows Link Between Genes, Seaside Vacations & Future Melanoma Risk

“Early-life UV exposure that confers risk for melanoma also plays a role in development of moles or melanocytic nevi, which can be both a biomarker for melanoma risk and occasionally an immediate precursor,” says Neil Box, PhD.

Read the rest of this entry

University of Colorado Hospital Now Offering Lung Cancer Screening

By: Jackie Brinkman AURORA, Colo. – Just in time for Lung Cancer Awareness Month, University…

Read the rest of this entry

CU Cancer Center brings specialty care to Colorado

Aurora, COLO. – The University of Colorado Cancer Center cemented relationships with three hospitals bringing…

Read the rest of this entry

Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests

A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.

Read the rest of this entry

Radiation of the brain may lead to cognitive dysfunction in cancer patients

Radiation and chemotherapy are the two most common treatments given to people diagnosed with cancer….

Read the rest of this entry

MOvember returns to the CU Cancer Center

A team at the University of Colorado Cancer Center is saying “no” to shaving for…

Read the rest of this entry

PNAS: From HIV to Cancer, IL-37 Regulates Immune System

“This is a case in which our understanding of basic biology could translate into applications across many disease types,” says Mayumi Fujita, MD, PhD.

Read the rest of this entry

After Decades of Research, Effectiveness of Phone Interventions for Cancer Patients and Survivors Still Unknown

“It’s time we did this the right way, once, so that we could discover the effectiveness or lack of effectiveness of these interventions once and for all moving forward,” says Sonia Okyuyama, MD.

Read the rest of this entry